12067-1-AP
antibody from Proteintech Group
Targeting: ATP5IF1
ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12067-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12067-1-AP, RRID:AB_2063159
- Product name
- ATPIF1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ATPIF1 antibody (Cat. #12067-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ATP synthase inhibitory factor subunit 1 regulates islet β-cell function via repression of mitochondrial homeostasis.
ATPIF1 maintains normal mitochondrial structure which is impaired by CCM3 deficiency in endothelial cells.
F1F0-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation.
The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase.
Zhang K, Bao R, Huang F, Yang K, Ding Y, Lauterboeck L, Yoshida M, Long Q, Yang Q
Laboratory investigation; a journal of technical methods and pathology 2022 Jan;102(1):69-79
Laboratory investigation; a journal of technical methods and pathology 2022 Jan;102(1):69-79
ATPIF1 maintains normal mitochondrial structure which is impaired by CCM3 deficiency in endothelial cells.
Wang K, Chen H, Zhou Z, Zhang H, Zhou HJ, Min W
Cell & bioscience 2021 Jan 9;11(1):11
Cell & bioscience 2021 Jan 9;11(1):11
F1F0-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation.
Tanton H, Voronina S, Evans A, Armstrong J, Sutton R, Criddle DN, Haynes L, Schmid MC, Campbell F, Costello E, Tepikin AV
Frontiers in physiology 2018;9:833
Frontiers in physiology 2018;9:833
The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase.
Ivanes F, Faccenda D, Gatliff J, Ahmed AA, Cocco S, Cheng CH, Allan E, Russell C, Duchen MR, Campanella M
British journal of pharmacology 2014 Sep;171(18):4193-206
British journal of pharmacology 2014 Sep;171(18):4193-206
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ATPIF1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ATPIF1. This antibody recognizes human, mouse, rat antigen. The ATPIF1 antibody has been validated for the following applications: ELISA, WB analysis.